BNP Paribas Arbitrage SA increased its stake in Masimo Corporation (NASDAQ:MASI) by 114.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 32,879 shares of the medical equipment provider’s stock after buying an additional 17,565 shares during the period. BNP Paribas Arbitrage SA owned 0.06% of Masimo Corporation worth $2,998,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Neuburgh Advisers LLC raised its position in shares of Masimo Corporation by 6.4% in the first quarter. Neuburgh Advisers LLC now owns 1,328 shares of the medical equipment provider’s stock valued at $124,000 after buying an additional 80 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Masimo Corporation by 32.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,782 shares of the medical equipment provider’s stock valued at $166,000 after buying an additional 434 shares during the period. Glen Harbor Capital Management LLC raised its position in shares of Masimo Corporation by 6.4% in the first quarter. Glen Harbor Capital Management LLC now owns 1,826 shares of the medical equipment provider’s stock valued at $170,000 after buying an additional 110 shares during the period. Dubuque Bank & Trust Co. raised its position in shares of Masimo Corporation by 3.4% in the second quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock valued at $170,000 after buying an additional 61 shares during the period. Finally, Bancorpsouth Inc. bought a new position in shares of Masimo Corporation during the first quarter valued at $203,000. 83.27% of the stock is owned by institutional investors.

Shares of Masimo Corporation (MASI) opened at 81.79 on Tuesday. The stock’s 50 day moving average is $90.44 and its 200 day moving average is $90.72. Masimo Corporation has a 12 month low of $53.78 and a 12 month high of $104.71. The firm has a market cap of $4.25 billion, a PE ratio of 13.41 and a beta of 0.80.

Masimo Corporation (NASDAQ:MASI) last posted its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.71 by $0.12. The company had revenue of $192.90 million during the quarter, compared to the consensus estimate of $189.03 million. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The business’s quarterly revenue was up 11.8% on a year-over-year basis. During the same period last year, the business earned $0.57 EPS. On average, analysts anticipate that Masimo Corporation will post $2.80 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece of content was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/masimo-corporation-masi-shares-bought-by-bnp-paribas-arbitrage-sa/1529121.html.

Several brokerages have weighed in on MASI. Zacks Investment Research lowered shares of Masimo Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, July 4th. BidaskClub lowered shares of Masimo Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Roth Capital increased their target price on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, July 19th. BTIG Research raised shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Monday, August 14th. Finally, Stifel Nicolaus began coverage on shares of Masimo Corporation in a research note on Monday, July 10th. They set a “buy” rating and a $105.00 target price for the company. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the company’s stock. Masimo Corporation has an average rating of “Hold” and a consensus target price of $95.00.

In other news, COO Anand Sampath sold 40,000 shares of the stock in a transaction dated Tuesday, July 11th. The stock was sold at an average price of $92.00, for a total transaction of $3,680,000.00. Following the transaction, the chief operating officer now owns 20,000 shares of the company’s stock, valued at approximately $1,840,000. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Sanford Fitch sold 11,000 shares of the stock in a transaction dated Thursday, August 17th. The shares were sold at an average price of $87.25, for a total value of $959,750.00. Following the transaction, the director now directly owns 72,249 shares in the company, valued at approximately $6,303,725.25. The disclosure for this sale can be found here. In the last three months, insiders have sold 126,000 shares of company stock worth $11,732,930. 16.60% of the stock is currently owned by insiders.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.